Reason for request
Inclusion
Clinical Benefit
| Substantial |
The actual benefit of NOVOEIGHT is substantial. |
Clinical Added Value
| no clinical added value |
NOVOEIGHT does not provide any improvement in actual benefit (level V, non-existent) in the treatment and prophylaxis of haemophilia A compared with other available treatments. |
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
Xn42QSRTj8Qyg6XG
Listen
